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A second means of coping with unfolded ER proteins
is the UPR (reviewed by Chapman et al., 1998). The
accumulation of unfolded ER proteins activates theSummary
transmembrane kinase/nuclease Ire1p (Cox et al., 1993;
Mori et al., 1993; Shamu and Walter, 1996), which initi-The unfolded protein response (UPR) regulates gene
expression in response to stress in the endoplasmic ates the nonconventional splicing of HAC1 mRNA. This
leads to production of Hac1p, a bZIP transcription factorreticulum (ER). We determined the transcriptional
scope of the UPR using DNA microarrays. Rather than (Cox and Walter, 1996; Mori et al., 1996; Sidrauski et
al., 1996; Sidrauski and Walter, 1997), and ultimatelyregulating only ER-resident chaperones and phospho-
lipid biosynthesis, as anticipated from earlier work, transcriptional induction of UPR target genes. Regula-
tion of gene expression by the UPR allows the cell tothe UPR affects multiple ER and secretory pathway
functions. Studies of UPR targets engaged in ER-asso- tolerate folding stress and presumably assists in correc-
tion of the insult that caused unfolded proteins to accu-ciated protein degradation (ERAD) reveal an intimate
coordination between these responses: efficient ERAD mulate (Cox et al., 1993; Mori et al., 1993).
While the mechanism by which the UPR signal isrequires an intact UPR, and UPR induction increases
ERAD capacity. Conversely, loss of ERAD leads to transmitted from the ER to the nucleus is well character-
ized, it is less clear how this response corrects misfold-constitutive UPR induction. Finally, simultaneous loss
of ERAD and the UPR greatly decreases cell viability. ing. Of the small number of UPR target genes identified
thus far, most encode ER-resident chaperones, as mightThus, the UPR and ERAD are dynamic responses re-
quired for the coordinated disposal of misfolded pro- be expected for a response to the accumulation of un-
folded proteins (Chapman et al., 1998). In addition, com-teins even in the absence of acute stress.
ponents of the phospholipid biosynthetic pathways are
Introduction targets, suggesting a role for the UPR in maintenance
and biogenesis of the ER membrane (Cox et al., 1997;
Proteins entering the secretory pathway fold within the Kagiwada et al., 1998). Identification of the complete
confines of the endoplasmic reticulum (ER). To support set of UPR target genes thus promised to provide insight
efficient folding, the ER maintains an environment en- into the means by which the cell copes with folding
riched in chaperones, glycosylation enzymes, and oxi- stress and adjusts the capacity of protein folding in the
doreductases (for a review, see Ellgaard et al., 1999). ER according to need. Here, we have used genome-
Despite this optimized environment, an inevitable con- wide expression analysis in conjunction with specific
sequence of the large flux of proteins through the ER mutations to identify genes whose expression is specifi-
is that the folding process occasionally fails, resulting cally induced by the UPR in the budding yeast Saccharo-
in the production of irrevocably misfolded proteins. Two myces cerevisiae.
distinct processes have been described that help eukary-
otic cells cope with this problem: ER-associated degra- Results
dation (ERAD) and the unfolded protein response (UPR).
The ERAD system eliminates misfolded proteins via Defining the Targets of the UPR
degradation in the cytosol (reviewed by Bonifacino and We identified transcriptional targets of the UPR by moni-
Weissman, 1998). Misfolded ER proteins are retro- toring mRNA levels using high-density oligonucleotide
translocated across the ER membrane into the cytosol, arrays (Wodicka et al., 1997). We induced the UPR by
where ubiquitin-conjugating enzymes target them for treating cells with two chemical agents that disrupt pro-
proteasomal degradation (Ward et al., 1995; McCracken tein folding in the ER: the strong reducing agent dithio-
threitol (DTT), which prevents disulfide bond formation,
5 To whom correspondence should be addressed (e-mail: jsw1@ and the drug tunicamycin, which inhibits N-linked glyco-
itsa.ucsf.edu [J. S. W.], walter@cgl.ucsf.edu [P. W.]). sylation. Neither of these agents is known to affect pro-6 These authors contributed equally to this work.
tein folding outside the secretory pathway. Furthermore,7 Present address: Genomics Institute of the Novartis Research
because these agents interfere with ER folding by differ-Foundation (GNF), 3115 Merryfield Row, San Diego, California
92121. ent mechanisms, any gene regulation resulting from
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Figure 1. Identification of the Transcriptional Targets of the UPR
(A) Determination of the canonical UPR. For each of the indicated nine conditions (wild-type cells treated with DTT for 15, 30, 60, or 120 min;
wild-type cells treated with tunicamycin (Tm) for 60 min; Dire1 cells treated with DTT or Tm for 60 min; or Dhac1 cells treated with DTT or Tm
for 60 min), the average of the log2 of fold induction for seven known UPR targets (KAR2, LHS1, ERO1, PDI1, EUG1, FKB2, and INO1) was
calculated.
(B) Graphical representation of the expression pattern for three DnaJ homologs. Correlation coefficients (P) were calculated for each gene in
the yeast genome, comparing its expression pattern in the nine conditions to that of the canonical profile. Represented here are three DnaJ
homologs, with their respective correlation values. JEM1 encodes an ER-resident protein, while MDJ1 and YDJ1 encode mitochondrial and
cytosolic proteins, respectively.
(C) Comparison of UPR-dependent induction by DTT and tunicamycin. UPR-dependent induction was calculated by dividing the average of
fold changes in wild-type cells by the average of fold changes in two UPR-deficient strains (see the Experimental Procedures). Points
representing ORFs that satisfy the criteria for being targets of the UPR (i.e., P value . 0.81, Z-test . 3.6, and average induction in wild-type
cells . 1.5) are red, while points representing all other genes are green. For illustration, positions of three previously known targets of the
UPR (ERO1, PDI1, and LHS1) are indicated, as well as two targets identified in this work (DER1 and HRD3).
(D) Distribution of UPR induction. Shown is a histogram of the number of ORFs at a given distance along the diagonal of the scatter plot in
(C), which we take as a combined measure of DTT and tunicamycin UPR-dependent induction. Green bars represent data from genes called
as nontargets of the UPR, while red bars represent the contribution from the set of target genes. Shown with a dotted line is the Gaussian
fit to the distribution of nontargets, which highlights the asymmetry of induction.
both treatments is likely to result from ER protein mis- comparison to an untreated control. Thus, for each ORF,
there are nine induction measurements: five from treat-folding rather than nonspecific effects.
We prepared RNA samples for array hybridization ment of a wild-type strain and four from treatment of
UPR-deficient strains.from wild-type cells grown under five conditions: expo-
sure to DTT for 15, 30, 60, or 120 min, or exposure to We then defined a canonical response profile for a
UPR target gene by combining the array expression datatunicamycin for 60 min. For each open reading frame
(ORF), we determined the fold change in expression due for seven previously reported UPR targets: KAR2, EUG1,
PDI1, LHS1, FKB2, ERO1, and INO1 (Chapman et al.,to each drug treatment by comparing its expression
level in the treated sample to its level in an untreated 1998). For each of the nine treatment conditions, we
defined the canonical response as the average of thecontrol. In order to eliminate from consideration ORFs
with UPR-independent transcriptional changes, we also fold changes in that condition for each of the known
target genes. As anticipated, UPR targets showedmeasured fold changes in strains bearing either a dele-
tion of IRE1 (Dire1) or HAC1 (Dhac1). These UPR-defi- strong induction in each of the wild-type conditions and
little or no induction in the four UPR-deficient conditionscient strains are unable to transduce the UPR signal
from the ER to the nucleus (Cox et al., 1993; Mori et al., (Figure 1A). The canonical profile shows that the UPR
is rapid: induction of target genes was essentially com-1993, 1996; Cox and Walter, 1996). We treated both
mutant strains with either DTT or tunicamycin for 60 plete after 15 min and was maintained over the time
course of DTT treatment. Thus, the time course of DTTmin and determined the fold change in expression by
Essential Coordination between the UPR and ERAD
251
Figure 2. Many Aspects of Secretory Path-
way Function Are Regulated by the UPR
A schematic diagram of the secretory path-
way, with a classification of the genes identi-
fied as targets of the UPR. See Table 1 for
details.
induction in effect provides four independent measure- Two genes that are known targets of the UPR (KAR2
and INO1) did not pass the strict statistical criterionments of UPR activity under fully induced conditions.
The magnitude of the response was comparable in DTT- (2.75 and 3.0 standard deviations, respectively) due to
significant residual upregulation in the mutant strains,and tunicamycin-treated cells.
We employed three criteria to identify novel targets as previously observed (Cox et al., 1993). Thus, the high
stringency of the criteria employed results in an under-of the UPR. First, we required targets of the UPR to
exhibit expression patterns that matched those of estimation of the full scope of the UPR. Despite this
stringent selection, we identified a large set comprisedknown UPR targets. For each ORF, we calculated the
correlation between the expression pattern of that ORF of 381 ORFs that are induced by both DTT and tuni-
camycin in an IRE1- and HAC1-dependent manner. Aand the canonical profile. We selected ORFs as candi-
date targets if this correlation was no worse than that database containing the complete data set can be found
at http://www.cell.com/cgi/content/full/101/3/249/DC1.of KAR2, the previously identified UPR target with the
lowest correlation to the canonical profile (P 5 0.81). We have also included transcriptional data from a strain
deleted for OPI1, a negative regulator of inositol andThis analysis is illustrated in Figure 1B, in which the
expression patterns for three DnaJ homologs are dis- membrane biosynthesis that is inhibited upon activation
of HAC1 (Cox et al., 1997). These data reveal that lossplayed along with their correlations to the canonical
profile. The gene encoding the ER-resident chaperone of OPI1 leads to induction of only a small subset of UPR
target genes. We conclude that the vast majority of UPRJem1p shows high correlation (P 5 0.98), suggesting
that JEM1 is a target of the UPR. In contrast, genes target genes defined here are not upregulated as a sec-
ondary consequence of membrane proliferation.encoding DnaJ homologs localized to the mitochondria
(MDJ1) or the cytosol (YDJ1) show little correlation (P 5 For every ORF, we then determined the UPR-depen-
dent induction due to a particular unfolding treatment20.70 and 20.56, respectively) and are therefore ex-
cluded from the target set. (DTT or tunicamycin) by dividing the average fold change
resulting from that treatment in wild-type cells by theSecond, we required that candidate UPR targets ex-
hibit inductions that differ between wild-type and UPR- average fold change in the UPR-deficient mutants. A
scatter plot of DTT induction versus the tunicamycindeficient mutant samples at a level of significance (3.6
standard deviations) corresponding to a difference that induction (Figure 1C) reveals that, as with known UPR
targets, the newly identified targets of the UPR (redwould occur by chance less than one time in 6400, i.e.,
less than one gene in the S. cerevisiae genome. Finally, points) are induced to similar levels by DTT and tuni-
camycin. Because the two unfolding agents have similarin order to eliminate ORFs that passed the criteria estab-
lished above due solely to decreases in expression in effects on gene expression, we projected this scatter
plot onto the diagonal (equal induction by DTT and tuni-the UPR-deficient mutants, we required that UPR tar-
gets show a mean change in the wild-type of greater camycin) and took the distance along this line as a mea-
sure of combined DTT and tunicamycin induction. Thisthan 1.5-fold. The set of genes satisfying these criteria
defines the HAC1- and IRE1-dependent response to ER analysis provides a single metric of UPR-dependent in-
duction by the two unfolding agents. A histogram of thisprotein misfolding.
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Table 1. Secretory Pathway Genes Upregulated by the UPR
TRANSLOCATION
Translocon SEC61, SBH1, SLS1
Posttranslational translocation SEC62, SEC71, SEC72
Signal peptidase SPC2
GLYCOSYLATION/MODIFICATION
Core oligosaccharide synthesis DPM1, PMI40, RHK1, SEC59
Oligosaccharyltransferase OST2, OST3, SWP1, WBP1
Glycoprotein processing ALG6, ALG7, MNS1, RAM2, STE24
GPI anchoring GAA1, GPI12, LAS21, MCD4
Golgi/O-linked glycosylation KTR1, MNN11, PMT1, PMT2, PMT3, PMT5
PROTEIN FOLDING
Chaperones FKB2, JEM1, LHS1, SCJ1, YFR041Ca
Disulfide bond formation ERO1, EUG1, MPD1, MPD2, PDI1
PROTEIN DEGRADATION
ER-associated degradation (ERAD) DER1, HRD1/DER3, HRD3, UBC7
Ubiquitin/proteasome DOA4, PEX4
VESICLE TRAFFICKING/TRANSPORT
Budding (ER-Golgi) ERV25, SEC12, SEC13, SEC16, SEC24, SED4,
SFB2, SFB3, YMR040W b
Fusion (ER-Golgi) BOS1, TRS120
Retrieval (Golgi-ER) ERD2, RER2, RET2, SEC26, SEC27
Distal secretion APL3, ARL3, BFR1, MYO5, SEC6, TUS1, YPT10
LIPID/INOSITOL METABOLISM
Fatty acid metabolism ACB1, HAP1, MGA2, YJR107W c
Heme biosynthesis DFR1, HEM12, HEM13, HEM15, RIB1
Phospholipid biosynthesis EPT1, INP51, LPP1, OP13, SCS3, SLC1
Sphingolipid biosynthesis LCB1
Sterol metabolism ARE1, HMG2, YHR073W d
VACUOLAR PROTEIN SORTING LUV1, STP22, VPS17, VPS35
CELL WALL BIOGENESIS CHS7, CSR1, ECM3, ECM8, ECM31, EXG2,
GAS5, PKC1, SPF1, YKR027W e, YOR239W f
Bold headings correspond to functional categories illustrated in Figure 2. Genes are assigned to subcategories according to summaries of
published data listed in the Saccharomyces Genome Database (SGD) and Yeast Protein Database (YPD).
a DnaJ homolog with predicted signal sequence. b Homolog of BAP-29 and BAP-31, sorting proteins that control anterograde transport of
certain membrane proteins from the ER to the Golgi complex (Ng et al., 1997). c Homolog of acylglycerol lipase. d Homolog of human oxysterol-
binding protein (OSBP). e Homolog of Chs6p, involved in localization of Chs3p. f Homolog of Chs5p, required for protease activation of Chs3p.
metric for all ORFs (Figure 1D) displays a significant The UPR Controls the Rate of ERAD
The induction of ERAD components was particularlydegree of asymmetry, with the newly identified UPR
intriguing, as it suggested coordination between thetargets (red bars) corresponding to the excess ORFs on
UPR and another pathway related to protein misfoldingthe right side of the distribution. The fact that there is
in the ER. We confirmed the genomic array measure-not a corresponding set of ORFs on the left side of the
ments of ERAD gene expression levels by Northern blothistogram indicates that the UPR is largely an inductive
analysis and found that the results were in good agree-transcriptional response, with little specific repression.
ment. DER1 and HRD3, nonessential genes required for
ERAD, are strongly induced upon tunicamycin treatment
Many Aspects of Secretory Function Are Regulated of wild-type cells but not Dire1 mutant cells (Figure 3).
by the UPR SEC61, an essential component of the translocon also
Our analysis reveals that the scope of the UPR is far required for ERAD (Pilon et al., 1997; Plemper et al.,
broader than anticipated by the functions of previously 1997; Zhou and Schekman, 1999), is similarly induced
reported target genes. The 381 ORFs that passed our in an IRE1-dependent manner. In contrast, transcription
criteria include 208 genes for which some functional of SRP54, which is also important for protein transloca-
information is available (named genes or their homologs) tion but not known to influence the rate of ERAD, is
and 173 genes for which no information is presently unresponsive to tunicamycin treatment.
available. Of the functionally characterized genes, 103 Since several genes important for ERAD are induced
are known or predicted by sequence homology to play by the UPR, we examined candidate genes to identify
roles in secretion or the biogenesis of secretory organ- novel ERAD components. One of these candidates,
elles. As expected, we observe induction of ER-resident YOL031c, was chosen on the basis of its homology to
chaperones and genes involved in phospholipid metab- a Yarrowia lipolytica gene (SLS1) that encodes a nones-
olism. However, these represent only a fraction of this sential ER-lumenal protein that is physically associated
set of target genes, which also includes several catego- with the translocon (BoisrameÂ et al., 1999). Hereafter,
ries of genes with functions throughout the secretory we refer to this gene as PER100 (protein processing in
pathway (Figure 2). These functional categories (detailed the ER; Ng et al., submitted).
in Table 1) include translocation, protein glycosylation, We measured ERAD rates using strains expressing
vesicular transport, cell wall biosynthesis, vacuolar pro- CPY* (prc1-1), a constitutively misfolded soluble secre-
tory protein and a well-characterized substrate for ERADtein targeting, and ER-associated degradation.
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of 25 6 1 min, as compared to 15 6 1 min in wild-type
cells; Figure 4B, circles). Given that an intact UPR is
necessary for efficient ERAD, we asked whether activa-
tion of the UPR is sufficient to increase the rate of degra-
dation. We constructed strains bearing a plasmid sys-
tem in which the spliced form of the HAC1 gene is driven
by a glucocorticoid-responsive element (GRE)-con-
taining promoter; the GRE-HAC1 gene and the glucocor-
ticoid receptor, a ligand-regulated transcriptional acti-
vator, are expressed in trans on separate high copy (2m)
plasmids. This system allowed us to induce the UPR by
expressing Hac1p upon addition of the glucocorticoid
receptor ligand deoxycorticosterone (DOC). After 90 min
of exposure to DOC, steady-state levels of Hac1p
reached a plateau, resulting in significant induction of
several UPR target genes tested by Northern blot (data
not shown). The rate of CPY* degradation was dramati-
cally increased in cells bearing GRE-HAC1 and treated
with DOC (half-life of 6 6 1 min; Figure 4C, diamonds)
compared to DOC-treated cells bearing the GRE vector
alone (half-life of 30 6 2 min; Figure 4C, squares). CellsFigure 3. Northern Blot Analysis Confirms UPR-Dependent Induc-
bearing the GRE vector alone degrade CPY* more slowlytion of Genes Involved in ERAD
than do the wild-type cells used in Figures 4A and 4B;Northern blot analysis was performed on the same RNA samples
that were used to collect the microarray data for cells treated with this difference may be explained by the diminished
tunicamycin (Tm) for 60 min. Shown are data for DER1 and HRD3, growth rate we observe for these strains, which bear
encoding dedicated ERAD components; SEC61, encoding a protein multiple 2m plasmids. In any event, degradation of CPY*
shared with the general translocation machinery; and SRP54, which
is accelerated in the DOC-induced samples expressingis involved in translocation but not ERAD. All expression levels were
HAC1 even when compared to the wild-type samplesnormalized against the ACT1 message levels and then against the
displayed in Figure 4A and 4B.expression level for the untreated wild-type sample. For compari-
son, the microarray data for wild-type cells treated with tunicamycin In the GRE-inducible system, HAC1-expressing cells
(Tm) found 3.9-, 3.4-, 2-, and 0.66-fold changes compared to un- induce UPR target genes in the absence of high levels
treated cells for DER1, HRD3, SEC61, and SRP54, respectively. of unfolded protein. We also measured ERAD after acti-
vating the UPR in wild-type cells with chemical agents
that interfere with protein folding. In marked contrast to(Knop et al., 1996). To facilitate immunoprecipitation of
the above experiments, in cells treated with tunicamycinCPY*, the prc1-1 gene, which was driven by its native
(Figure 4D, circles) or DTT (Figure 4D, diamonds) for 1(PRC1) promoter, was modified by addition of se-
hr prior to pulse labeling, ERAD was completely blocked.quences encoding a C-terminal HA tag (Ng et al., submit-
These treatments generate pathologically high levels ofted). In each of the experiments described below, we
misfolded protein; the blockage of ERAD may thereforepulse-labeled cells with 35S-methionine/cysteine, chased
result from saturation of the capacity of the ERAD sys-over a 45 min time course, immunoprecipitated with
tem despite activation of the UPR and transcriptionalantibodies against the HA epitope, and subjected sam-
upregulation of several ERAD components under theseples to SDS-PAGE and autoradiography. The rate of
conditions (see the Discussion). Consistent with this,disappearance of CPY* represents the rate of ERAD.
expression of high levels of a single misfolded proteinWe compared the rate of degradation of CPY* in a
results in slower ERAD: cells expressing CPY* from theDper100 mutant to the rate in wild-type cells and in the
strong promoter TDH3 grow at a normal rate but degradeDder1 mutant, in which ERAD is completely blocked
CPY* with significantly slower kinetics than when the(Knop et al., 1996). In wild-type cells, CPY* was de-
protein is expressed under control of the native (PRC1)graded with a half-life of 15 6 1 min (Figure 4A, squares),
promoter (half-life of 3061 min; Figure 4D, triangles).a value in agreement with published observations. As
anticipated, a Dder1 mutant failed to measurably de-
grade CPY* over the time course (Figure 4A, diamonds). Mutations in ERAD Components Result
in Constitutive Activation of the UPRThe Dper100 mutant displayed an intermediate pheno-
type, with a CPY* half-life of 24 6 2 min (Figure 4A, Previous work has indicated that mutations in genes
required for ERAD do not cause a detectable growthtriangles). This stabilization is roughly comparable to
that reported for strains containing ERAD-deficient al- phenotype under normal growth conditions (Knop et al.,
1996). While it is possible that this is the case becauseleles of KAR2 (Plemper et al., 1997) and deletion of the
PMR1 ion transporter, also required for wild-type levels degradation of misfolded proteins is required for life
only under conditions of extreme folding stress, an alter-of ERAD (DuÈ rr et al., 1998). Thus, the PER100 gene
product plays a role in maintaining efficient ERAD, per- native explanation is that the UPR can compensate for a
defect in ERAD, eliminating misfolded proteins by otherhaps through an activity at the translocon.
Because several UPR target genes are required for means. In the latter case, a loss of ERAD function would
result in an accumulation of unfolded proteins in the ERERAD, we asked whether mutant strains unable to in-
duce the UPR are also deficient in ERAD. Indeed, the and chronic activation of the UPR.
We tested for constitutive activation of the UPR inDire1 mutant degraded CPY* at a reduced rate (half-life
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Figure 4. The Rate of Degradation of CPY* Is
Controlled by the UPR
Cells expressing an HA-tagged copy of CPY*
were 35S-radiolabeled and then chased for the
indicated time. The rate of degradation of
CPY* was analyzed by immunoprecipitation
followed by SDS-PAGE and autoradiography.
Quantitation of CPY*, normalized against in-
tensity in the time 5 0 sample, was plotted
against chase time, and a half-life (see text)
computed by fitting a single exponential
curve to each graph. Error bars indicate stan-
dard deviation from the average of four (A, B,
and D) or three (C) independent experiments.
Shown is the comparison of the rate of CPY*
degradation in:
(A) Cells deleted for the known ERAD compo-
nent DER1 (Dder1) or PER100 (Dper100) ver-
sus wild-type cells (WT).
(B) Cells deleted for IRE1 (Dire1) versus wild-
type cells (WT).
(C) Cells expressing Hac1p under control of the glucocorticoid-responsive promoter (GRE-HAC1) versus cells not expressing Hac1p (GRE-
vector). Both samples were treated with DOC for 90 min prior to pulse labeling.
(D) Cells treated with DTT or tunicamycin (Tm) or expressing CPY* under control of the strong promoter TDH3 (high CPY*) versus a control
(untreated).
cells lacking DER1, HRD1, HRD3, or the newly identified both Dire1 and either Dhrd1 or Dhrd3 mutations dis-
played a stronger phenotype than the Dire Dder1 spores.ERAD gene PER100 using a sensitive reporter of UPR
activation. The reporter construct consists of the gene These strains showed poor viability following meiosis,
grew irregularly at room temperature, and entirely failedencoding green fluorescent protein (GFP) driven by four
repeats of the unfolded protein response element from to grow at 378C (Figure 5B). Similarly, strains containing
deletions in both the IRE1 and PER100 genes failed tothe KAR2 promoter (UPRE; Cox and Walter, 1996; Mori
et al., 1996). Comparison of steady-state levels of GFP grow beyond the few cell stage despite the fact that
loss of PER100 alone caused little or no growth defectfluorescence in Dder1, Dhrd1, Dhrd3, and Dper100
strains to those of wild-type cells (Figure 5A, left panel) (data not shown).
reveals a z2-fold induction of the UPR under normal
growth conditions in these mutants. Both wild-type and Discussion
ERAD-deficient cells showed similar levels of maximal
GFP expression under DTT treatment (Figure 5A, right Using high-density oligonucleotide arrays in conjunction
with strains bearing specific defects in the UPR, we havepanel), indicating that the observed induction of the UPR
is not the result of a nonspecific increase in GFP levels defined the transcriptional scope of the UPR. Remark-
ably, the UPR affects virtually every stage of the secre-in the mutant cells.
tory pathway. From entry into the ER (translocation),
through processing (folding, covalent modification, andMutations in the UPR and ERAD
Are Synthetically Lethal sorting), until exit from the pathway (arrival at a target
organelle, secretion from the cell, or degradation), aWe have thus far demonstrated that the rate of ERAD
is modestly decreased in the absence of a functional secretory protein's progress is influenced by the tran-
scriptional targets of the UPR. The breadth of this re-UPR (Figure 4B). In addition, ERAD-deficient cells show
a constitutive, partial activation of the UPR. Together, sponse suggests that genes involved in many secretory
functions, including but not limited to ER-resident chap-these data suggest that the UPR and ERAD cooperate
to eliminate misfolded proteins under normal growth erones, are required for maintenance of the specialized
protein folding environment.conditions, predicting that simultaneous loss of both
pathways should be more detrimental to the cell than The scope of the UPR is focused in large part on the
secretory pathway, with approximately half of the 208the loss of either one alone.
To test for such synthetic effects, we constructed UPR target genes for which functional data are available
playing roles in secretion. The 173 transcriptional targetsdiploid strains containing heterozygous deletions in
IRE1 as well as one of the previously identified genes of the UPR with no known function are therefore excel-
lent candidates for genes with important secretory func-required for ERAD (DER1, HRD1, or HRD3) or the newly
identified ERAD gene PER100. Following meiosis, spores tions. Indeed, our expression data and functional stud-
ies allowed us to identify the previously uncharacterizedbearing both Dire1 and Dder1 mutations germinated nor-
mally but failed to grow at 378C (Figure 5B). By contrast, S. cerevisiae homolog of the Y. lipolytica gene SLS1,
referred to above as PER100, as a novel componentthe single mutants showed no growth defect under ei-
ther condition. Consistent with the fact that there is a required for efficient ERAD.
Despite its breadth, the UPR results in a specific re-broader spectrum of substrates that are dependent on
Hrd1p and Hrd3p for their ERAD-mediated degradation modeling of the secretory pathway rather than the indis-
criminate upregulation of all ER or secretory pathway(Hampton et al., 1996; Knop et al., 1996), spores bearing
Essential Coordination between the UPR and ERAD
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Figure 5. Genetic Interaction between Muta-
tions in UPR and ERAD Genes
(A) Deletion of genes involved in ERAD po-
tentiates the UPR. Cells contained an inte-
grated reporter gene in which GFP was driven
by four copies of the unfolded protein re-
sponse element (UPRE). Wild-type cells (WT),
cells deleted for one of the known ERAD com-
ponents DER1 (Dder1), HRD1 (Dhrd1), or
HRD3 (Dhrd3), as well as cells deleted for
PER100 (Dper100) were grown to mid-log
phase and analyzed for GFP expression by
FACS. Shown on the left is the mean GFP
fluorescence for each strain. Strains were an-
alyzed for constitutive expression of GFP (ª0
mM DTTº) or UPR-induced expression after
exposure to 2 mM DTT for 90 min (ª2 mM
DTTº).
(B) Deletion of genes involved in ERAD is syn-
thetically lethal with absence of the UPR.
The indicated yeast strains bearing either a
single deletion in one of three well-character-
ized ERAD genes (DER1, HRD1, or HRD3) or
this deletion combined with a deletion of IRE1
were plated at 258C and 378C. For compari-
son, a strain bearing a deletion of IRE1 and an
isogenic parent (WT) are shown. In all cases,
roughly equal numbers of cells were spotted.
components. For example, many components of the either addition of GPI anchors or protein glycosylation
are lethal in the absence of UPR function (Ng et al.,COP-II vesicle coat involved in ER-Golgi trafficking are
targets, including two strongly induced homologs of submitted). Moreover, UPR induction in mammalian
cells was recently shown to accelerate synthesis of theSEC24 that have been suggested to play a role in export
of specific cargo proteins (Roberg et al., 1999). In con- dolichol-oligosaccharides employed in N-linked glyco-
sylation (Doerrler and Lehrman, 1999). In the event thattrast, components of the COP-I/ªcoatomerº involved in
retrograde transport are less well represented, and direct attempts to increase the efficiency of folding fail,
induction of specific COP-II components might enablethose that are regulated by the UPR typically show only
modest induction. Similarly, of the ER-resident chaper- efficient packaging of cargo proteins (possibly including
unfolded proteins) into anterograde vesicles or simplyones involved in folding or secretion of specific sub-
strates (Ellgaard et al., 1999), only CHS7, required for increase the overall capacity of anterograde transport.
Such an increase in secretory capacity might facilitatematuration of chitin synthase III (Trilla et al., 1999), is
upregulated. This specificity suggests that rather than targeting of misfolded species to the vacuole for degra-
dation (Hong et al., 1996), consistent with our observa-merely increasing the capacity of the secretory pathway,
the UPR results in selective induction of those activities tion that several genes involved in vacuolar targeting are
also UPR targets. Similarly, induction of phospholipidthat are essential under folding stress, e.g., in the cases
mentioned above, enhanced anterograde transport of biosynthetic enzymes would generate new membranes,
thereby increasing the volume of the ER, simultaneouslya particular subset of secretory proteins, or folding of
proteins involved in maintaining cell wall integrity. The diluting unfolded proteins and preparing the compart-
ment to receive an influx of newly synthesized foldingset of UPR target genes may therefore specify those
activities required to optimize protein folding in the ER. factors. Finally, induction of ERAD components directly
enhances the clearance of misfolded proteins from theHow might the set of UPR target genes act in a con-
certed manner to promote efficient folding? An attrac- ER to the cytosol.
Our functional studies demonstrate that the capacitytive hypothesis is that a critical function of the UPR is
to reduce the lumenal concentration of misfolded pro- of the ERAD system is readily saturated under condi-
tions of ER stress and that the UPR plays a direct roletein, by either directly refolding proteins or removing
them from the ER (Figure 6). In this model, abundant in counteracting this saturation. We find that the UPR is
necessary for efficient ERAD function, as UPR-deficientchaperones would bind to misfolded species, prevent
aggregation, and promote folding. Similarly, glycosyla- cells degrade CPY* at a reduced rate; these results are
in qualitative agreement with recent reports that bothtion enzymes would assist in the folding of proteins that
require carbohydrate modification to attain their proper full-length CPY* (Ng et al., submitted) and a truncated
allele of CPY* (Casagrande et al., 2000 [April issue ofconformation. Consistent with this suggestion, we found
in an independent study that mutations that compromise Molecular Cell]) are stabilized in the Dire1 mutant. This
Cell
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Although the UPR enhances ER degradation capacity
under acute folding stress, the ERAD pathway also plays
a critical and previously undescribed role in the disposal
of misfolded proteins even under normal growth condi-
tions. Loss of ERAD function in Dder1, Dhrd1, Dhrd3,
and Dper100 strains leads to chronic accumulation of
unfolded proteins in the ER, as evidenced by constitu-
tive activation of the UPR. Recently, Zhou and Schek-
man (1999) reported that SEC61 alleles with specific
defects in ERAD, as well as deletion of several other
ERAD components, also cause constitutive UPR induc-
tion. Thus, the chronic accumulation of misfolded pro-
teins in the ER appears to be a general consequence
of loss of ERAD. Earlier studies suggested that even if it
were constitutively active, ERAD has little physiological
importance in the absence of an acute stress, as loss
of ERAD function does not lead to a detectable growth
phenotype (Knop et al., 1996; Zhou and Schekman,
1999). Here, we show that this lack of phenotype results
from a compensatory effect of UPR induction: deletionFigure 6. Schematic Model Illustrating the Coordinated Action of
of any of three well-characterized ER-resident ERADthe UPR and ERAD
components (DER1, HRD1, HRD3) or the newly identifiedProteins enter the ER in an unfolded form, whereupon they either
fold, oligomerize, and pass on to the later secretory pathway or ERAD component PER100 results in dramatic loss of
become irreversibly misfolded and are eliminated by the ERAD ma- viability in a Dire1 strain. In a parallel study, we found
chinery. Either cellular stress or loss of ERAD results in accumulation that deletion of either of two genes encoding cytosolic
of misfolded proteins and thereby activation of the UPR (filled-in
ERAD components, the membrane-bound ubiquitin-con-arrow). The UPR acts to reduce levels of misfolded proteins by
jugating enzyme Ubc7p and the proteasome regulatorenhancing folding to the native state, promoting transit to the distal
Son1p/Rpn4p, also shows a synthetic lethal phenotypesecretory pathway, and enhancing the rate of ERAD, while simulta-
neously reducing the formation of misfolded species. when combined with loss of IRE1 (Ng et al., submitted).
Hence, loss of ERAD function at any location (ER lumen,
ER membrane, or proteasome) results in a requirement
for UPR-mediated clearance of misfolded proteins.decrease in ERAD rate is likely to result from chronic
Taken together, our observations argue that a fractionmisfolding in Dire1 strains rather than from direct loss
of the proteins passing through the ER will inevitablyof the ERAD machinery, as Dire1 cells do not show
misfold and that removal of these misfolded polypep-decreased basal transcription of ERAD genes (Figure
tides is an essential process under all growth conditions.3). The notion that ERAD capacity can be readily satu-
The chronic misfolding of proteins in the ER is likely torated is further supported by the observation that treat-
reflect the inherent difficulty of folding secretory andment with DTT or tunicamycin, both of which generate
membrane proteins, which unlike cytosolic proteins of-high levels of unfolded ER proteins, dramatically de-
ten require covalent modifications, such as disulfidecreases the rate of CPY* degradation. High levels of
bonds and glycosylation, as well as the precise orderingeven a single misfolded protein can substantially de-
of transmembrane domains across and within the lipidcrease the rate of degradation: expression of CPY* from
bilayer. In the absence of a functional UPR, the ERADa strong promoter resulted in accumulation of the pro-
capacity is sufficient to dispose of this flux provided thetein and a doubling of its half-life, consistent with the
cell does not face an unusual stress. Conversely, whenidea that ERAD capacity can be saturated by high con-
the UPR is available in a cell with diminished ERADcentrations of substrate. In striking contrast to the DTT
capacity, misfolded proteins can still be handled by mul-and tunicamycin treatments, we find that when the UPR
tiple mechanisms, including refolding by chaperones,is induced by expression of Hac1p, which does not
clearance from the ER by anterograde vesicular trans-cause accumulation of unfolded proteins, the rate of
port, or an alternate means of degradation, e.g., in theERAD is significantly increased, thus demonstrating that
vacuole or by the action of other UPR-induced ERADthe UPR plays a direct role in enhancing ERAD. It has
genes. Thus, the UPR and ERAD represent partially over-recently been postulated that the rate-limiting step in
lapping or compensatory means to the same essentialthe degradation of a protein through ERAD is the conver-
end: elimination of misfolded secretory proteins, whichsion of N-linked oligosaccharide from the Man9 to the
are inevitably generated during the course of normalMan8 form (Jakob et al., 1998), a reaction catalyzed by
growth.the glycosylase Mns1p. We found that UPR activation
results in the upregulation of MNS1, raising the intriguing
Experimental Procedurespossibility that the UPR accelerates ERAD in part via
increased expression of an enzyme that catalyzes the
General Proceduresrate-limiting step; in this scenario, during times of folding
Yeast manipulations were performed using standard methods (Sher-
stress, activation of the UPR would reduce the time man, 1991), except that the pH of YPD was lowered to that of
available for a protein to fold before being targeted for synthetic defined media (pH 5 5.4) to inhibit oxidation of DTT. All
incubations were at 308C, unless otherwise indicated.degradation.
Essential Coordination between the UPR and ERAD
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Plasmid Construction followed curated data available online at SGD (http://genome-www.
stanford.edu/Saccharomyces).Plasmid pRS425-GRE, which contains the glucocorticoid respon-
sive element upstream of a multiple cloning site, was generated by The calculation of UPR-dependent DTT induction used in Figure
subcloning the XhoI-SacI fragment of p2UG (Schena et al., 1991) 1C is:
into the corresponding sites of pRS425 (Sikorski and Hieter, 1991).
Plasmid pCP274, which contains the spliced form of the HAC1 gene 1
4
((WT.D.15) 1 (WT.D.30) 1 (WT.D.60) 1 (WT.D.120)) 2downstream of the GRE promoter, was generated by cloning the
DraI/SmaI fragment of pRC43 (Cox et al., 1997) into the SmaI cloning 1
2
((Dire1.D.60) 1 (Dhac1.D.60))site of pRS425-GRE. Plasmid pKT058, which encodes a GFP re-
porter gene driven by four repeats of the KAR2 UPRE, was generated
by subcloning the UPRE- and GFP-containing ClaI-SacI fragment The calculation of UPR-dependent tunicamycin induction used in
of pKT007 (Pollard et al., 1998) into pRS304 (Sikorski and Hieter, Figure 1C is:
1991). Plasmid pCP280, which contains the prc1-1 gene encoding




((Dire1.T.60) 1 (Dhac1.T.60))ligating a blunted AccI fragment of pDN431 (Ng et al., submitted)
into blunted, BamHI-linearized pG-1 (2m TRP1; Schena et al., 1991).
CPY* Degradation Assay
Strains bearing a low copy CPY*-HA expression plasmid (Ng et al.,Yeast Strains
submitted) were grown to OD600 5 1.0. Cell pellets were washedThe wild-type strains W303-1B and JC103 (which was derived from
twice, resuspended at 3 OD/ml in medium lacking methionine, andW303-1B by integration of a b-gal UPR reporter into the HIS3 and
incubated for 1 hr at 308C with 1 mg/ml tunicamycin, 2 mM DTT, orLEU2 loci), the Dire1 strain CS165, and the Dhac1 strain JC408 are
100 mM DOC as indicated. Newly synthesized polypeptides wereas described (Cox et al., 1993; Cox and Walter, 1996). The PER100,
pulse labeled by addition of 20 mCi/OD ProMix (Amersham) for 20HRD1, and HRD3 deletion strains were derived from a W303-1B
min and chased by addition of 2 mM each cold methionine andparent by replacing the entire open reading frame of each gene with
cysteine. Time points were taken by transferring 1 ml aliquots intoan auxotrophic marker (LEU2 for PER100 or HIS3 for HRD1 and HRD3)
chilled tubes containing 100 ml 100% TCA and 3 ml 3M sodiumusing the method of Pringle and coworkers (Longtine et al., 1998).
azide and freezing immediately in liquid nitrogen. Immunoprecipita-Strains used in the experiments described in Figure 4D were W303-
tions were performed by the method of Gaynor et al. (1994) except1B transformed with pT2.GN795 (Schena et al., 1991), which con-
that after preclearing, supernatants were incubated for 4 hr at 48Ctains the glucocorticoid receptor under control of the GPD promoter
with 7 ml of 16B11 anti-HA antibody (BAbCo) and immunoprecipi-and either pRS425-GRE (ªGRE-vectorº) or pCP274 (ªGRE-HAC1º).
tated by addition of 1 ml rabbit anti-mouse antibody (Jackson) and
25 ml protein A-Sepharose slurry and incubation for 30 min.
Genomic Arrays: Sample Preparation and Hybridization
Biotinylated cRNA samples were prepared and processed largely
FACS Analysisas described previously (Wodicka et al., 1997). In brief, cultures of
Strains containing an integrated UPRE-GFP reporter were con-wild-type (JC103), CS165, or JC408 strains were grown to mid-log
structed by transforming W303-1B (wild-type), Dder1, Dhrd1, andphase in rich medium and treated with either 1 mg/ml tunicamycin
Dhrd3 with EcoRV-linearized pKT007 or by transforming Dper100(Tm) or 2 mM DTT. At the indicated times, cells were treated with
with EcoRV-linearized pKT058. Integrations were confirmed by ge-20 mM azide, recovered from 250 ml aliquots by centrifugation, and
nomic PCR analysis. All strains were grown to mid-log phasefrozen in liquid nitrogen. Total RNAs were prepared by freeze/thaw/
(OD600 5 0.5) and then cultures were grown in the presence or ab-hot phenol extraction (Schmitt et al., 1990), and mRNA was purified
sence of 2 mM DTT for 1.5 hr to induce the UPR. GFP fluorescenceusing the PolyATtract system (Promega) according to the manufac-
was measured by FACS analysis on a FACScan instrument (Becton-turer's instructions. First-strand cDNA synthesis was performed us-
Dickinson).ing AMV (Promega) according to the manufacturer's instructions.
Second-strand syntheses, cRNA amplifications, fragmentations,
and hybridizations were conducted as described previously (Wod- Acknowledgments
icka et al., 1997).
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